Anika Therapeutics Inc (ANIK)
25.60
+0.34
(+1.35%)
USD |
NASDAQ |
May 10, 16:00
25.60
0.00 (0.00%)
After-Hours: 20:00
Anika Therapeutics Cash from Operations (Quarterly): 3.638M for Dec. 31, 2023
Cash from Operations (Quarterly) Chart
Historical Cash from Operations (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 3.638M |
| September 30, 2023 | 6.485M |
| June 30, 2023 | -8.293M |
| March 31, 2023 | -3.618M |
| December 31, 2022 | 0.481M |
| September 30, 2022 | 2.709M |
| June 30, 2022 | 3.088M |
| March 31, 2022 | -1.869M |
| December 31, 2021 | 4.472M |
| September 30, 2021 | 2.062M |
| June 30, 2021 | 4.294M |
| March 31, 2021 | -2.431M |
| December 31, 2020 | 2.587M |
| September 30, 2020 | 5.865M |
| June 30, 2020 | 3.568M |
| March 31, 2020 | 1.045M |
| December 31, 2019 | 13.02M |
| September 30, 2019 | 10.05M |
| June 30, 2019 | 5.47M |
| March 31, 2019 | 8.462M |
| December 31, 2018 | 10.01M |
| September 30, 2018 | 10.84M |
| June 30, 2018 | 4.471M |
| March 31, 2018 | 9.592M |
| December 31, 2017 | 6.981M |
| Date | Value |
|---|---|
| September 30, 2017 | 12.10M |
| June 30, 2017 | 6.271M |
| March 31, 2017 | 15.46M |
| December 31, 2016 | 6.07M |
| September 30, 2016 | 11.32M |
| June 30, 2016 | -0.982M |
| March 31, 2016 | 8.044M |
| December 31, 2015 | 16.12M |
| September 30, 2015 | 8.906M |
| June 30, 2015 | 10.90M |
| March 31, 2015 | 3.984M |
| December 31, 2014 | 14.76M |
| September 30, 2014 | 7.386M |
| June 30, 2014 | 4.240M |
| March 31, 2014 | 13.60M |
| December 31, 2013 | 8.006M |
| September 30, 2013 | 7.526M |
| June 30, 2013 | 3.564M |
| March 31, 2013 | 6.069M |
| December 31, 2012 | 4.812M |
| September 30, 2012 | 2.202M |
| June 30, 2012 | 5.224M |
| March 31, 2012 | -1.690M |
| December 31, 2011 | 7.307M |
| September 30, 2011 | 2.976M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (Quarterly) Range, Past 5 Years
-8.293M
Minimum
Jun 2023
13.02M
Maximum
Dec 2019
2.770M
Average
3.088M
Median
Jun 2022
Cash from Operations (Quarterly) Benchmarks
| The Cooper Companies Inc | 122.70M |
| Staar Surgical Co | 21.68M |
| OrthoPediatrics Corp | -6.69M |
| NexGel Inc | -0.587M |
| Innovative Eyewear Inc | -1.136M |
Cash from Operations (Quarterly) Related Metrics
| Cash from Investing (Quarterly) | -1.84M |
| Cash from Financing (Quarterly) | 0.342M |
| Free Cash Flow | -7.215M |
| Free Cash Flow Per Share (Quarterly) | 0.1228 |
| Free Cash Flow to Equity (Quarterly) | 1.798M |
| Free Cash Flow to Firm (Quarterly) | 1.798M |
| Free Cash Flow Yield | -1.92% |